SINUVA is a prescription steroid-releasing (mometasone furoate) implant indicated for the treatment of nasal polyps in patients 18 years or older who have had ethmoid sinus surgery. SINUVA expands in the sinus opening and delivers an anti-inflammatory steroid directly to the site of polyp disease for up to 90 days.
Manufacturer: Intersect ENT